LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA813991
NCI NIH HHS
Grant: F31 CA232630
National Institutes of Health
Grant: NS095642
National Institutes of Health
Grant: L32 MD010147
NCATS NIH HHS
Grant: UL1 TR001422
National Institutes of Health
Grant: NS102669
NCI NIH HHS
Grant: P50 CA221747
NINDS NIH HHS
Grant: R01 NS095634
National Institutes of Health
Grant: NS095634
NCI Cancer Center
Grant: P30CA060553
NCI NIH HHS
Grant: T32 CA070085
National Institutes of Health
Grant: CA070085
NCI NIH HHS
Grant: P30 CA008748
NINDS NIH HHS
Grant: R01 NS117104
NINDS NIH HHS
Grant: R01 NS093843
NINDS NIH HHS
Grant: R01 NS102669
NINDS NIH HHS
Grant: R01 NS115403
MeSH Terms
Keywords